An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
Authors
Keywords
-
Journal
NATURE CELL BIOLOGY
Volume 16, Issue 5, Pages 457-468
Publisher
Springer Nature
Online
2014-04-21
DOI
10.1038/ncb2953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling
- (2013) Peter G. Miller et al. CANCER CELL
- A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
- (2013) Yanyan Zheng et al. CANCER CELL
- Integrin v 3 and Fibronectin Upregulate Slug in Cancer Cells to Promote Clot Invasion and Metastasis
- (2013) L. M. Knowles et al. CANCER RESEARCH
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- Cancer stem cell in the progression and therapy of pancreatic cancer
- (2013) Lantao Xu Frontiers in Bioscience-Landmark
- FOSL1 Controls the Assembly of Endothelial Cells into Capillary Tubes by Direct Repression of αv and β3 Integrin Transcription
- (2013) Sandrine Evellin et al. MOLECULAR AND CELLULAR BIOLOGY
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- The developing cancer stem-cell model: clinical challenges and opportunities
- (2012) Louis Vermeulen et al. LANCET ONCOLOGY
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- Cancer stem cells, tumor dormancy, and metastasis
- (2012) Purvi Patel et al. Frontiers in Endocrinology
- Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane
- (2011) L. Scheppke et al. BLOOD
- Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR
- (2011) Paul Workman et al. CANCER CELL
- Galectin-3 – A jack-of-all-trades in cancer
- (2011) Anna U. Newlaczyl et al. CANCER LETTERS
- ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin- v 3-Dependent Mechanisms
- (2011) M. Jinushi et al. CANCER RESEARCH
- Antibody Conjugate Therapeutics: Challenges and Potential
- (2011) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma
- (2011) Tina Cascone et al. JOURNAL OF CLINICAL INVESTIGATION
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
- (2011) Trever G. Bivona et al. NATURE
- A MEK-independent role for CRAF in mitosis and tumor progression
- (2011) Ainhoa Mielgo et al. NATURE MEDICINE
- Ras trafficking, localization and compartmentalized signalling
- (2011) Ian A. Prior et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling
- (2011) Vinagolu K. Rajasekhar et al. Nature Communications
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Retinoid signaling regulates breast cancer stem cell differentiation
- (2010) Christophe Ginestier et al. CELL CYCLE
- Metastatic potential of tumor-initiating cells in solid tumors
- (2010) Amit et al. Frontiers in Bioscience-Landmark
- Targeting Breast Cancer Stem Cells
- (2010) Suling Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- K-Ras Nanoclustering Is Subverted by Overexpression of the Scaffold Protein Galectin-3
- (2008) R. Shalom-Feuerstein et al. CANCER RESEARCH
- The Mammary Progenitor Marker CD61/ 3 Integrin Identifies Cancer Stem Cells in Mouse Models of Mammary Tumorigenesis
- (2008) F. Vaillant et al. CANCER RESEARCH
- Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
- (2008) J. A. Engelman et al. CLINICAL CANCER RESEARCH
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD61 enriches long-term repopulating hematopoietic stem cells
- (2007) Terumasa Umemoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started